Literature DB >> 23405969

Assessment of left ventricular size and function during cardiac surgery. An intraoperative evaluation of six two-dimensional echocardiographic methods with real time three-dimensional echocardiography as a reference.

Manuel Grossgasteiger1, Maximilian D Hien, Bastian Graser, Helmut Rauch, Matthias Gondan, Johann Motsch, Christian Rosendal.   

Abstract

Transesophageal echocardiography is recommended to monitor left ventricular (LV) size and function in various operations. Generally, two-dimensional (2D) methods are applied intraoperatively. The aim of this study was to compare the accuracy and feasibility of 6 commonly used 2D methods to assess LV function during surgery. LV function in 120 consecutive patients was evaluated. Real time three-dimensional transesophageal echocardiograpy (3DTEE) served as reference. End-diastolic and end-systolic volumes and ejection fraction (EF) were analyzed with Simpson's method of discs (monoplane [MP] and biplane [BP]), eyeball method, Teichholz' method, and speckle tracking (ST) methods. Furthermore, fractional area change (FAC) and peak systolic pressure rise (dP/dt) were determined. Each 2D method was evaluated regarding correlation and agreement with 3DE, intra- and interobserver variability and the time required for evaluation. Simpson BP showed the strongest correlation and best agreement with 3DE for EF (limits of agreement 3.7 ± 11.6%) and volumes. Simpson MP showed similar agreement with 3DE compared to ST (2.8 ± 14.5% vs. 2.0 ± 15.3% and 3.8 ± 14.4% vs. 1.9 ± 15.6%, respectively). Both the eyeball method and Teichholz' method showed wide limits of agreement (-1.5 ± 18.2% and 5.2 ± 22.1%, respectively). DP/dt did not correlate with 3DE. FAC and ST FAC showed similar agreement. Application of 3DE (429 ± 108 seconds) took the longest time, and the eyeball method took the shortest time (8 ± 5 seconds) for analysis. Simpson BP is the most accurate intraoperative 2D method to evaluate LV function, followed by long-axis MP evaluations. Short-axis views were less accurate but may be suited for monitoring. We do not recommend using dP/dt.
© 2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  Simpson's method of discs; Teichholz' method; intraoperative three-dimensional transesophageal echocardiography; peak systolic pressure rise; prospective observational study; speckle tracking

Mesh:

Year:  2013        PMID: 23405969     DOI: 10.1111/echo.12116

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  6 in total

Review 1.  [Perioperative transesophageal echocardiography in non-cardiac surgery. Update].

Authors:  D Wally; C Velik-Salchner
Journal:  Anaesthesist       Date:  2015-09       Impact factor: 1.041

Review 2.  [Application fields of intraoperative transesophageal 3D echocardiography].

Authors:  H Magunia; P Rosenberger
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

3.  [Intraoperative transesophageal echocardiography for emergency diagnostics in noncardiac surgery patients].

Authors:  C Dumps; V Umrath; B Rupprecht; J Schimpf; J Benak
Journal:  Anaesthesist       Date:  2021-11-25       Impact factor: 1.041

4.  Assessment of left atrial volume and mechanical functions using real-time three-dimensional echocardiography in patients with mitral annular calcification.

Authors:  Adil Bayramoğlu; Hakan Taşolar; Yılmaz Ömür Otlu; Şıho Hidayet; Fuat Kurt; Adil Doğan; Hasan Pekdemir
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

5.  Pretreatment with glucose-insulin-potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial.

Authors:  Marc Licker; Thomas Reynaud; Najia Garofano; Tornike Sologashvili; John Diaper; Christoph Ellenberger
Journal:  J Clin Monit Comput       Date:  2019-02-20       Impact factor: 2.502

Review 6.  Echocardiography in shock management.

Authors:  Anthony S McLean
Journal:  Crit Care       Date:  2016-08-20       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.